Claire Ashman

Efficacy and safety of an anti–IL-13 mAb in patients with severe asthma: A randomized trial

Erika H. De Boever, Claire Ashman, Anthony Cahn et al. · Journal of Allergy and Clinical Immunology · 2014 · 142 citations

Clinical Immunology, Asthma, Allergy +10

GRID: A Novel Grb-2-Related Adapter Protein That Interacts with the Activated T Cell Costimulatory Receptor CD28

Jonathan H. Ellis, Claire Ashman, M. Neil Burden et al. · The Journal of Immunology · 2000 · 61 citations

Novel Adapter Protein, Signal Transduction, Signaling Pathway +13

A phase 1, randomized, placebo‐controlled, dose‐escalation study of an anti‐IL‐13 monoclonal antibody in healthy subjects and mild asthmatics

Peter Hodsman, Claire Ashman, Anthony Cahn et al. · British Journal of Clinical Pharmacology · 2012 · 57 citations · Full text

The Conserved Process of TCR/CD3 Complex Down-Modulation by SIV Nef Is Mediated by the Central Core, Not Endocytic Motifs

Todd M. Schaefer, Ian M. Bell, Melanie E. Pfeifer et al. · Virology · 2002 · 36 citations

Signal Transduction, Cell Interaction, Tcr/cd3 Complex Down-modulation +11

Structure-Activity Relationships Among a New Class of Antiviral Heterosubstituted 2',3'-Dideoxynucleoside Analogues

Tarek S. Mansour, Haolun Jin, Wei Wang et al. · Nucleosides Nucleotides & Nucleic Acids · 1995 · 23 citations

Immunology, Antiviral Drug, Antiviral Heterosubstituted 2',3'-Dideoxynucleoside +18